Coencapsulation of Arsenic‐ and Platinum‐based Drugs for Targeted Cancer Treatment
- 17 November 2009
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 48 (49), 9295-9299
- https://doi.org/10.1002/anie.200903655
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxideMolecular Cancer Therapeutics, 2009
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Endocytic mechanisms for targeted drug delivery☆Advanced Drug Delivery Reviews, 2007
- Lipid Encapsulation of Arsenic Trioxide Attenuates Cytotoxicity and Allows for Controlled Anticancer Drug ReleaseJournal of the American Chemical Society, 2006
- Opposing effects of arsenic trioxide on hepatocellular carcinomas in miceCancer Science, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Tri(allyl)- and tri(methylallyl)arsine complexes of palladium(ii) and platinum(ii): synthesis, spectroscopy, photochemistry and structuresNew Journal of Chemistry, 2003
- Synthesis of inorganic nanophase materials in supramolecular protein cagesNature, 1991
- Reactions of platinum(II) aqua complexes. 1. Multinuclear (platinum-195, nitrogen-15, and phosphorus-31) NMR study of reactions between the cis-diamminediaquaplatinum(II) cation and the oxygen-donor ligands hydroxide, perchlorate, nitrate, sulfate, phosphate, and acetateInorganic Chemistry, 1984
- Hydroxo-bridged platinum(II) complexes. 4. Crystal structure and vibrational spectra of di-.mu.-hydroxo-bis[diammineplatinum(II)] carbonate dihydrate, [(NH3)2Pt(OH)2Pt(NH3)2](CO3).2H2OInorganic Chemistry, 1978